Cargando…
Inflammatory Response in Islet Transplantation
Islet cell transplantation is a promising beta cell replacement therapy for patients with brittle type 1 diabetes as well as refractory chronic pancreatitis. Despite the vast advancements made in this field, challenges still remain in achieving high frequency and long-term successful transplant outc...
Autores principales: | Kanak, Mazhar A., Takita, Morihito, Kunnathodi, Faisal, Lawrence, Michael C., Levy, Marlon F., Naziruddin, Bashoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021753/ https://www.ncbi.nlm.nih.gov/pubmed/24883060 http://dx.doi.org/10.1155/2014/451035 |
Ejemplares similares
-
Outcomes of Islet Autotransplantation in Chronic Pancreatitis Patients with Complete Acinar Atrophy
por: Yoshimatsu, Gumpei, et al.
Publicado: (2020) -
Anti-inflammatory Approach With Early Double Cytokine Blockade (IL-1β and TNF-α) Is Safe and Facilitates Engraftment in Islet Allotransplantation
por: Onaca, Nicholas, et al.
Publicado: (2020) -
Pancreatic β-Cell–Derived IP-10/CXCL10 Isletokine Mediates Early Loss of Graft Function in Islet Cell Transplantation
por: Yoshimatsu, Gumpei, et al.
Publicado: (2017) -
Cluster Analysis of Self-Monitoring Blood Glucose Assessments in Clinical Islet Cell Transplantation for Type 1 Diabetes
por: Takita, Morihito, et al.
Publicado: (2011) -
Role of Exosomes in Islet Transplantation
por: Mattke, Jordan, et al.
Publicado: (2021)